Mortality differences in pulmonary fibrosis among the most populated states in the United States - 19/10/21
, Matheni Sathananthan bAbstract |
Background |
Recent studies suggest that the mortality rate of pulmonary fibrosis (PF) in the U.S. is decreasing. However, the mortality trends and demographic differences of PF among the states have not been evaluated.
Objective |
To evaluate PF-related mortality rates and trends in the nine most populated states in the U.S.
Methods |
Population-based study using the Multiple Cause of Death Database available through the Centers for Disease Control and Prevention website. PF-related deaths were identified using ICD codes.
Results |
From 2004 to 2018, average annual mortality rates ranged from being the lowest in New York (110.8 per 1,000,000) to the highest in North Carolina (195.3 per 1,000,000). The mortality rates showed a decline in the majority of the states and were stable in the other states. The most significant declines were in California and Michigan. The average mortality rates in males were higher than females in all the states (rate ratio ranged from 1.56 in Texas to 1.81 in New York) and the decline in the mortality rates was more pronounced compared to males in most states. The mortality rates in Blacks were lower compared to Whites in all the states (rate ratio ranged from 0.47 in New York to 0.69 in Ohio) and the decline in the mortality rates over the period was more significant than in Whites.
Conclusions |
There is substantial variation in mortality rates and mortality trends between states and different demographics. Further studies are needed to evaluate the environmental factors, diagnostic accuracy, and coding practices contributing to these differences.
Le texte complet de cet article est disponible en PDF.Highlights |
• | Pulmonary fibrosis-related mortality rates/trends vary significantly between states. |
• | The mortality differential between states is maintained among both sex and race. |
• | Mortality rates decreased in most states especially among females and blacks. |
• | State mortality differences are likely related to smoking/environmental exposures. |
• | Diagnostic capabilities/access to health care are also likely contributing factors. |
Keywords : Pulmonary fibrosis, Mortality, State, Race
Abbreviations : PF, IPF, CDC Wonder, UCD
Plan
Vol 187
Article 106565- octobre 2021 Retour au numéro
Article précédent
- The impact of demographic disparities in the presentation of sarcoidosis: A multicenter prospective study
- Ying Zhou, Alicia K. Gerke, Elyse E. Lower, Alexander Vizel, Deepak Talwar, Irina Strambu, Joel Francesqui, Jacobo Sellares, Michiru Sawahata, Ogugua Ndili Obi, Sonoko Nagai, Kiminobu Tanizawa, Marc A. Judson, Florence Jeny, Dominique Valeyre, Marina Dornfeld Cunha Castro, Carlos Pereira, Meyer Balter, Robert P. Baughman
- Actigraphy informs distinct patient-centered outcomes in Pre-COPD
- Jianhong Chen, Lemlem Weldemichael, Siyang Zeng, Brian Giang, Jeroen Geerts, Wendy Czerina Ching, Melissa Nishihama, Warren M. Gold, Mehrdad Arjomandi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?